These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

318 related items for PubMed ID: 19415659

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Pyrrolo[2,3-a]carbazoles as potential cyclin dependent kinase 1 (CDK1) Inhibitors. Synthesis, biological evaluation, and binding mode through docking simulations.
    Fousteris MA, Papakyriakou A, Koutsourea A, Manioudaki M, Lampropoulou E, Papadimitriou E, Spyroulias GA, Nikolaropoulos SS.
    J Med Chem; 2008 Feb 28; 51(4):1048-52. PubMed ID: 18232654
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Design, synthesis and biological evaluation of N-phenylsulfonylnicotinamide derivatives as novel antitumor inhibitors.
    Zhang H, Lu X, Zhang LR, Liu JJ, Yang XH, Wang XM, Zhu HL.
    Bioorg Med Chem; 2012 Feb 15; 20(4):1411-6. PubMed ID: 22277588
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. 4-(Heteroarylaminomethyl)-N-(2-aminophenyl)-benzamides and their analogs as a novel class of histone deacetylase inhibitors.
    Fréchette S, Leit S, Woo SH, Lapointe G, Jeannotte G, Moradei O, Paquin I, Bouchain G, Raeppel S, Gaudette F, Zhou N, Vaisburg A, Fournel M, Yan PT, Trachy-Bourget MC, Kalita A, Robert MF, Lu A, Rahil J, Robert Macleod A, Besterman JM, Li Z, Delorme D.
    Bioorg Med Chem Lett; 2008 Feb 15; 18(4):1502-6. PubMed ID: 18207391
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Synthesis of 4-(acylaminomethyl)benzamides and their evaluation as potential anticancer agents.
    Schlitzer M, Sattler I, Friese A, Zündorf I, Dingermann T.
    Anticancer Res; 2000 Feb 15; 20(3A):1723-6. PubMed ID: 10928099
    [Abstract] [Full Text] [Related]

  • 13. Design, synthesis and docking studies on benzamide derivatives as histone deacetylase inhibitors.
    Lu A, Luo H, Shi M, Wu G, Yuan Y, Liu J, Tang F.
    Bioorg Med Chem Lett; 2011 Aug 15; 21(16):4924-7. PubMed ID: 21741834
    [Abstract] [Full Text] [Related]

  • 14. Design, synthesis, and in vitro antitumor activity of new 1,4-diarylimidazole-2-ones and their 2-thione analogues.
    Congiu C, Cocco MT, Onnis V.
    Bioorg Med Chem Lett; 2008 Feb 01; 18(3):989-93. PubMed ID: 18164978
    [Abstract] [Full Text] [Related]

  • 15. Synthesis and biological evaluation of imidazol-2-one derivatives as potential antitumor agents.
    Xue N, Yang X, Wu R, Chen J, He Q, Yang B, Lu X, Hu Y.
    Bioorg Med Chem; 2008 Mar 01; 16(5):2550-7. PubMed ID: 18226907
    [Abstract] [Full Text] [Related]

  • 16. Antitumor agents. 234. Design, synthesis, and biological evaluation of novel 4beta-[(4' '-benzamido)-amino]-4'-o-demethyl-epipodophyllotoxin derivatives.
    Xiao Z, Bastow KF, Vance JR, Sidwell RS, Wang HK, Chen MS, Shi Q, Lee KH.
    J Med Chem; 2004 Oct 07; 47(21):5140-8. PubMed ID: 15456257
    [Abstract] [Full Text] [Related]

  • 17. Antitumor studies. Part 5: Synthesis, antitumor activity, and molecular docking study of 5-(monosubstituted amino)-2-deoxo-2-phenyl-5-deazaflavins.
    Shrestha AR, Ali HI, Ashida N, Nagamatsu T.
    Bioorg Med Chem; 2008 Oct 15; 16(20):9161-70. PubMed ID: 18819815
    [Abstract] [Full Text] [Related]

  • 18. Structure-aided optimization of kinase inhibitors derived from alsterpaullone.
    Kunick C, Zeng Z, Gussio R, Zaharevitz D, Leost M, Totzke F, Schächtele C, Kubbutat MH, Meijer L, Lemcke T.
    Chembiochem; 2005 Mar 15; 6(3):541-9. PubMed ID: 15696597
    [Abstract] [Full Text] [Related]

  • 19. Synthesis and biological evaluation of 3,5-diaminoindazoles as cyclin-dependent kinase inhibitors.
    Lee J, Choi H, Kim KH, Jeong S, Park JW, Baek CS, Lee SH.
    Bioorg Med Chem Lett; 2008 Apr 01; 18(7):2292-5. PubMed ID: 18353638
    [Abstract] [Full Text] [Related]

  • 20. Design, synthesis and preliminary biological evaluation of N-hydroxy-4-(3-phenylpropanamido)benzamide (HPPB) derivatives as novel histone deacetylase inhibitors.
    Jiao J, Fang H, Wang X, Guan P, Yuan Y, Xu W.
    Eur J Med Chem; 2009 Nov 01; 44(11):4470-6. PubMed ID: 19608304
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.